Cargando…

Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)

Although considerable research highlights the interactions between obstructive sleep apnea-hypopnea syndrome (OSAHS) and cardiovascular diseases, the effect of mandibular advancement device (MAD) treatment on cardiovascular complications in OSAHS patients remains unclear. We evaluated the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chunyan, Kang, Wenjing, Zhang, Shilong, Qiao, Xing, Yang, Xiuchun, Zhou, Zheng, Lu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042252/
https://www.ncbi.nlm.nih.gov/pubmed/32098974
http://dx.doi.org/10.1038/s41598-020-60034-1
_version_ 1783501272585863168
author Liu, Chunyan
Kang, Wenjing
Zhang, Shilong
Qiao, Xing
Yang, Xiuchun
Zhou, Zheng
Lu, Haiyan
author_facet Liu, Chunyan
Kang, Wenjing
Zhang, Shilong
Qiao, Xing
Yang, Xiuchun
Zhou, Zheng
Lu, Haiyan
author_sort Liu, Chunyan
collection PubMed
description Although considerable research highlights the interactions between obstructive sleep apnea-hypopnea syndrome (OSAHS) and cardiovascular diseases, the effect of mandibular advancement device (MAD) treatment on cardiovascular complications in OSAHS patients remains unclear. We evaluated the effect of OSAHS treatment with MADs on the myocardium. All methods in this study were in accordance with relevant guidelines and regulations of the medical ethics committee in Hospital of Stomatology, Hebei Medical University approved the work. Thirty New Zealand rabbits were randomized into three groups: the control group, Group OSAHS, and Group MAD. Hydrophilic polyacrylamide gel was injected into the soft palate of the rabbits to induce OSAHS. In Group MAD, a MAD was positioned after OSAHS induction. All animals were induced to sleep in a supine position for 4–6 h/day for 8 weeks. Echocardiography was used to determine the structure and function of the heart. The histological changes were detected by optical microscopy and transmission electron microscopy (TEM). The levels of ET-1(endothelin-1) and Ang II (Angiotensin II) in the plasma were measured by an enzyme-linked immunosorbent assay (ELISA). The expression of ET-1 mRNA in heart tissue was detected by RT-PCR. Histological abnormalities, left ventricular hypertrophy, and left ventricular dysfunctions were demonstrated in Group OSAHS, and the abnormities were rescued with MAD treatment. Higher levels of plasma ET-1 and Ang II and elevated expression of ET-1 mRNA in cardiac tissue were detected in Group OSAHS compared with Group MAD and the control group. The blood oxygen saturation was negatively correlated with the levels of ET-1 and Ang II. OSAHS-induced elevated levels of ET-1 and Ang II may be attributed to myocardial structural abnormalities and dysfunction. Early treatment of MADs may play an important role in preventing myocardial damage in OSAHS rabbit model.
format Online
Article
Text
id pubmed-7042252
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70422522020-03-03 Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) Liu, Chunyan Kang, Wenjing Zhang, Shilong Qiao, Xing Yang, Xiuchun Zhou, Zheng Lu, Haiyan Sci Rep Article Although considerable research highlights the interactions between obstructive sleep apnea-hypopnea syndrome (OSAHS) and cardiovascular diseases, the effect of mandibular advancement device (MAD) treatment on cardiovascular complications in OSAHS patients remains unclear. We evaluated the effect of OSAHS treatment with MADs on the myocardium. All methods in this study were in accordance with relevant guidelines and regulations of the medical ethics committee in Hospital of Stomatology, Hebei Medical University approved the work. Thirty New Zealand rabbits were randomized into three groups: the control group, Group OSAHS, and Group MAD. Hydrophilic polyacrylamide gel was injected into the soft palate of the rabbits to induce OSAHS. In Group MAD, a MAD was positioned after OSAHS induction. All animals were induced to sleep in a supine position for 4–6 h/day for 8 weeks. Echocardiography was used to determine the structure and function of the heart. The histological changes were detected by optical microscopy and transmission electron microscopy (TEM). The levels of ET-1(endothelin-1) and Ang II (Angiotensin II) in the plasma were measured by an enzyme-linked immunosorbent assay (ELISA). The expression of ET-1 mRNA in heart tissue was detected by RT-PCR. Histological abnormalities, left ventricular hypertrophy, and left ventricular dysfunctions were demonstrated in Group OSAHS, and the abnormities were rescued with MAD treatment. Higher levels of plasma ET-1 and Ang II and elevated expression of ET-1 mRNA in cardiac tissue were detected in Group OSAHS compared with Group MAD and the control group. The blood oxygen saturation was negatively correlated with the levels of ET-1 and Ang II. OSAHS-induced elevated levels of ET-1 and Ang II may be attributed to myocardial structural abnormalities and dysfunction. Early treatment of MADs may play an important role in preventing myocardial damage in OSAHS rabbit model. Nature Publishing Group UK 2020-02-25 /pmc/articles/PMC7042252/ /pubmed/32098974 http://dx.doi.org/10.1038/s41598-020-60034-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Liu, Chunyan
Kang, Wenjing
Zhang, Shilong
Qiao, Xing
Yang, Xiuchun
Zhou, Zheng
Lu, Haiyan
Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
title Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
title_full Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
title_fullStr Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
title_full_unstemmed Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
title_short Mandibular Advancement Devices Prevent the Adverse Cardiac Effects of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
title_sort mandibular advancement devices prevent the adverse cardiac effects of obstructive sleep apnea-hypopnea syndrome (osahs)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042252/
https://www.ncbi.nlm.nih.gov/pubmed/32098974
http://dx.doi.org/10.1038/s41598-020-60034-1
work_keys_str_mv AT liuchunyan mandibularadvancementdevicespreventtheadversecardiaceffectsofobstructivesleepapneahypopneasyndromeosahs
AT kangwenjing mandibularadvancementdevicespreventtheadversecardiaceffectsofobstructivesleepapneahypopneasyndromeosahs
AT zhangshilong mandibularadvancementdevicespreventtheadversecardiaceffectsofobstructivesleepapneahypopneasyndromeosahs
AT qiaoxing mandibularadvancementdevicespreventtheadversecardiaceffectsofobstructivesleepapneahypopneasyndromeosahs
AT yangxiuchun mandibularadvancementdevicespreventtheadversecardiaceffectsofobstructivesleepapneahypopneasyndromeosahs
AT zhouzheng mandibularadvancementdevicespreventtheadversecardiaceffectsofobstructivesleepapneahypopneasyndromeosahs
AT luhaiyan mandibularadvancementdevicespreventtheadversecardiaceffectsofobstructivesleepapneahypopneasyndromeosahs